Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
90.30
-3.60 (-3.83%)
At close: Mar 12, 2026

Cosmo Pharmaceuticals Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4621,6771,0228181,0031,105
Market Cap Growth
33.60%64.05%24.91%-18.39%-9.22%-10.15%
Enterprise Value
1,3581,5679027809621,066
Last Close Price
90.30105.2061.4947.8056.2859.21
PE Ratio
--8.18-58.9149.16
Forward PE
1311.08-7.7828.2335.5163.09
PS Ratio
15.0717.294.089.489.9416.37
PB Ratio
3.213.682.162.182.192.08
P/TBV Ratio
5.195.953.483.4314.099.52
P/FCF Ratio
--6.9045.4135.34149.55
P/OCF Ratio
--6.7138.7230.5484.48
EV/Sales Ratio
14.0016.163.609.039.5415.80
EV/EBITDA Ratio
250.64332.636.0190.3823.6557.74
EV/EBIT Ratio
--6.48-34.7192.64
EV/FCF Ratio
-87.41-6.0943.2633.92144.35
Debt / Equity Ratio
0.010.010.000.010.370.33
Debt / EBITDA Ratio
0.730.730.010.184.149.20
Debt / FCF Ratio
--0.010.106.0523.85
Net Debt / Equity Ratio
-0.24-0.24-0.28-0.12-0.14-0.10
Net Debt / EBITDA Ratio
-23.41-23.41-0.88-5.23-1.64-2.94
Net Debt / FCF Ratio
7.107.10-0.89-2.50-2.35-7.34
Asset Turnover
0.170.170.460.140.130.09
Inventory Turnover
4.484.483.273.063.293.50
Quick Ratio
5.805.803.393.221.4511.77
Current Ratio
7.187.184.194.071.5712.99
Return on Equity (ROE)
-0.70%-0.70%29.31%-2.47%3.58%4.75%
Return on Assets (ROA)
-0.69%-0.69%15.80%-0.18%2.24%0.99%
Return on Invested Capital (ROIC)
-1.87%-1.89%35.80%-0.50%4.68%2.46%
Return on Capital Employed (ROCE)
-1.20%-1.20%24.80%-0.40%5.00%1.40%
Earnings Yield
-0.23%-0.20%12.23%-1.23%1.70%2.03%
FCF Yield
-1.06%-0.93%14.49%2.20%2.83%0.67%
Dividend Yield
2.02%1.86%3.13%3.90%1.84%1.66%
Payout Ratio
--24.09%-90.61%-
Buyback Yield / Dilution
2.73%2.73%-1.94%1.95%2.83%-16.81%
Total Shareholder Return
4.75%4.59%1.19%5.85%4.68%-15.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.